167 related articles for article (PubMed ID: 2734788)
1. The effect of phenobarbital on the metabolism and excretion of thyroxine in rats.
McClain RM; Levin AA; Posch R; Downing JC
Toxicol Appl Pharmacol; 1989 Jun; 99(2):216-28. PubMed ID: 2734788
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of propylthiouracil, amiodarone, diphenylhydantoin, phenobarbital, and 3-methylcholanthrene on hepatic and renal T4 metabolism and thyroid gland function in rats.
De Sandro V; Chevrier M; Boddaert A; Melcion C; Cordier A; Richert L
Toxicol Appl Pharmacol; 1991 Nov; 111(2):263-78. PubMed ID: 1957312
[TBL] [Abstract][Full Text] [Related]
3. Hepatobiliary disposition of thyroid hormone in Mrp2-deficient TR- rats: reduced biliary excretion of thyroxine glucuronide does not prevent xenobiotic-induced hypothyroidism.
Lecureux L; Dieter MZ; Nelson DM; Watson L; Wong H; Gemzik B; Klaassen CD; Lehman-McKeeman LD
Toxicol Sci; 2009 Apr; 108(2):482-91. PubMed ID: 19211616
[TBL] [Abstract][Full Text] [Related]
4. Increased thyroxine turnover and thyroidal function after stimulation of hepatocellular binding of thyroxine by phenobarbital.
Oppenheimer JH; Bernstein G; Surks MI
J Clin Invest; 1968 Jun; 47(6):1399-406. PubMed ID: 5653217
[TBL] [Abstract][Full Text] [Related]
5. Effects of pethoxamid treatment on the disposition of thyroxine in rats.
Chandrasekaran A; Bentley K; McClanahan R; Nallani G
Toxicol Appl Pharmacol; 2024 Jun; 487():116959. PubMed ID: 38734151
[TBL] [Abstract][Full Text] [Related]
6. The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: implications for thyroid gland neoplasia.
McClain RM
Toxicol Pathol; 1989; 17(2):294-306. PubMed ID: 2675280
[TBL] [Abstract][Full Text] [Related]
7. Detection of thyroid toxicants in a tier I screening battery and alterations in thyroid endpoints over 28 days of exposure.
O'Connor JC; Frame SR; Davis LG; Cook JC
Toxicol Sci; 1999 Sep; 51(1):54-70. PubMed ID: 10496677
[TBL] [Abstract][Full Text] [Related]
8. Hepatic microsomal enzyme induction and thyroid function in rats treated with high doses of phenobarbital or chlorpromazine.
Attia MA; Aref H
Dtsch Tierarztl Wochenschr; 1991 Jun; 98(6):209-13. PubMed ID: 1832377
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanism of simvastatin-induced thyroid hypertrophy and follicular cell adenoma in the rat.
Smith PF; Grossman SJ; Gerson RJ; Gordon LR; Deluca JG; Majka JA; Wang RW; Germershausen JI; MacDonald JS
Toxicol Pathol; 1991; 19(3):197-205. PubMed ID: 1780636
[TBL] [Abstract][Full Text] [Related]
10. In vitro accumulation of thyroid hormones by cultured rat hepatocytes and the biliary excretion of iodothyronines in rats treated with a novel histamine H2-receptor antagonist.
Poole A; Jones RB; Pritchard D; Catto L; Leonard T
Toxicology; 1989 Nov; 59(1):23-36. PubMed ID: 2573172
[TBL] [Abstract][Full Text] [Related]
11. The effect of antipyrine, phenobarbitol and rifampicin on thyroid hormone metabolism in man.
Ohnhaus EE; Bürgi H; Burger A; Studer H
Eur J Clin Invest; 1981 Oct; 11(5):381-7. PubMed ID: 6800809
[TBL] [Abstract][Full Text] [Related]
12. Evidence of chemical stimulation of hepatic metabolism by an experimental acetanilide (FOE 5043) indirectly mediating reductions in circulating thyroid hormone levels in the male rat.
Christenson WR; Becker BD; Wahle BS; Moore KD; Dass PD; Lake SG; Van Goethem DL; Stuart BP; Sangha GK; Thyssen JH
Fundam Appl Toxicol; 1996 Feb; 29(2):251-9. PubMed ID: 8742323
[TBL] [Abstract][Full Text] [Related]
13. Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in rats.
Wong H; Lehman-McKeeman LD; Grubb MF; Grossman SJ; Bhaskaran VM; Solon EG; Shen HS; Gerson RJ; Car BD; Zhao B; Gemzik B
Toxicol Sci; 2005 Apr; 84(2):232-42. PubMed ID: 15673846
[TBL] [Abstract][Full Text] [Related]
14. The effects on rat thyroid function of an hepatic microsomal enzyme inducer.
Johnson S; McKillop D; Miller J; Smith IK
Hum Exp Toxicol; 1993 Mar; 12(2):153-8. PubMed ID: 8096714
[TBL] [Abstract][Full Text] [Related]
15. Effect of the cardiac inotropic drug, OPC 8212, on pituitary-thyroid function in the rat.
Lueprasitsakul W; Fang SL; Alex S; Braverman LE
Endocrinology; 1991 Jun; 128(6):2709-14. PubMed ID: 1903694
[TBL] [Abstract][Full Text] [Related]
16. Polychlorinated biphenyl congeners that increase the glucuronidation and biliary excretion of thyroxine are distinct from the congeners that enhance the serum disappearance of thyroxine.
Martin LA; Wilson DT; Reuhl KR; Gallo MA; Klaassen CD
Drug Metab Dispos; 2012 Mar; 40(3):588-95. PubMed ID: 22187485
[TBL] [Abstract][Full Text] [Related]
17. Male rat hepatic UDP-glucuronosyltransferase activity toward thyroxine. Activation and induction properties--relation with thyroxine plasma disappearance rate.
de Sandro V; Catinot R; Kriszt W; Cordier A; Richert L
Biochem Pharmacol; 1992 Apr; 43(7):1563-9. PubMed ID: 1567478
[TBL] [Abstract][Full Text] [Related]
18. Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats.
Barter RA; Klaassen CD
Toxicol Appl Pharmacol; 1994 Sep; 128(1):9-17. PubMed ID: 8079359
[TBL] [Abstract][Full Text] [Related]
19. Increased biliary excretion of thyroxine by microsomal enzyme inducers.
Vansell NR; Klaassen CD
Toxicol Appl Pharmacol; 2001 Nov; 176(3):187-94. PubMed ID: 11714251
[TBL] [Abstract][Full Text] [Related]
20. Effects of ethinyl estradiol and phenobarbital on bile acid synthesis and biliary bile acid and cholesterol excretion.
Davis RA; Kern F
Gastroenterology; 1976 Jun; 70(6):1130-5. PubMed ID: 1269874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
